lysophosphatidic acid has been researched along with sodium arsenite in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bowen, BP; Brophy, CM; Flynn, CR; Komalavilas, P; Lopes, LB; Panitch, A; Seal, B; Smoke, C; Yi, Z | 1 |
1 other study(ies) available for lysophosphatidic acid and sodium arsenite
| Article | Year |
|---|---|
A novel cell permeant peptide inhibitor of MAPKAP kinase II inhibits intimal hyperplasia in a human saphenous vein organ culture model.
Topics: Animals; Aorta; Arsenites; Cell Movement; Cells, Cultured; Collagen; Connective Tissue Growth Factor; Enzyme Inhibitors; Fibronectins; Heat-Shock Proteins; HSP27 Heat-Shock Proteins; Humans; Hyperplasia; Intracellular Signaling Peptides and Proteins; Lysophospholipids; Microscopy, Confocal; Molecular Chaperones; Muscle, Smooth, Vascular; p38 Mitogen-Activated Protein Kinases; Peptides; Phosphorylation; Protein Array Analysis; Protein Serine-Threonine Kinases; Rats; Saphenous Vein; Sodium Compounds; Tissue Culture Techniques; Tunica Intima | 2010 |